X-Nico

6 unusual facts about Charité


Center for Anatomy of the Charité

The Center for Anatomy of the Charité is one of the centers of the Universitätsmedizin Berlin Charité in Berlin whose primary goals are anatomy teaching and research.

Grazer AK

The club arose from an informal association of local academics around the medical student Georg August Wagner from Prague, later a professor at the Charles University and the Charité in Berlin.

Gregor Žerjav

The last years of his life he suffered tuberculosis; for an attempt of operative surgery he went to Berlin to the Charité as one of the first patients of Ferdinand Sauerbruch when using the iron lung there.

Pluristem Therapeutics

In 2007 Pluristem entered into a collaborative research agreement with the Charité medical school in Berlin for a period of five years.

Ruth Berlau

She died in the Charité hospital after setting her bed alight with a cigarette.

Sauerbruch – Das war mein Leben

Professor Sauerbruch joins the scene and sends her into the surgical section of the Charité.


Baie-Mahault

A leprosarium, or leper's house, was operated by the Soeurs de la Charite and closed in 1954.

Gérard Locardi

He has been mainly a painter who found his inspiration in antique themes, two of his paintings are exhibited in the Chapelle de la Charité in Carpentras, Provence, France.

Historical mortality rates of puerperal fever

See also a similar underreporting practice at the Charité in Berlin, Joseph Hermann Schmidt.

Mysore literature in Kannada

The Jain poet Devachandra (1770–1841), a native of Kankagiri, was in the court of Krishnaraja III and authored three noted works: Pujyapada Charite, a poem on the life of the Jain saint Pujyapada in sangatya metre; Ramakathavatara, the poet's Jain version of the Hindu epic Ramayana in champu metre; and Rajavalikathe (1838), a biographical account of the Mysore royal family, some earlier poets, and stories of religious importance.

Saponin

The research groups of Professor Hendrik Fuchs (Charité University, Berlin, Germany) and Dr David Flavell (Southampton General Hospital, United Kingdom) are working together toward the development of Gypsophila saponins for use in combination with immunotoxins or other targeted toxins for patients with leukaemia, lymphoma and other cancers.


see also